AUS
NZ
UK
CA
USA
IND
Highlights
Scancell Holdings shares progress in its cancer immunotherapy programmes.
Clinical trial updates released by IXICO and hVIVO.
Thor Explorations and Oriole Resources report new exploration activity.
Scancell Holdings (LSE:SCLP), part of the biotechnology sector, reported continued progress in its work on cancer immunotherapy. The company is developing treatments targeting solid tumours and has disclosed new information around its trial strategy and regulatory interactions. This update is one of several across the biotech and exploration segments, marking a notable session for healthcare and mining-focused entities. Other biotech companies such as IXICO (LSE:IXI) and hVIVO (LSE:HVO) also released operational developments tied to trial monitoring, service execution, and platform advancements.
Clinical Imaging and Trial Services: IXICO Developments
IXICO provided an operational update related to its contract services for neurodegenerative disease studies. The company delivers imaging solutions used in trial evaluation phases, offering platforms to support sponsors involved in global clinical development.
Details shared included ongoing contributions to client studies and the application of its digital technologies in managing clinical imaging protocols. These updates follow the company’s continued involvement in structured trial support programmes for pharmaceutical partners.
hVIVO Confirms Milestones in Infectious Disease Research
hVIVO outlined recent activity related to its specialist services in controlled human infection modelling. The company focuses on trial execution, volunteer recruitment, and clinical infrastructure centred on viral research.
Operational progress during the period was linked to studies conducted under existing contracts. Clinical laboratory activity and facility use remained part of the execution model across ongoing engagements. The company also highlighted staffing and participant metrics relevant to its core services.
Mining and Exploration: Thor and Oriole Announcements
Thor Explorations shared operational updates regarding its gold production site. The company released information on its extraction and processing activities, with announcements covering logistics and material throughput.
In a separate update, Oriole Resources disclosed developments tied to its Cameroon projects. Key highlights included on-site geological surveys, permit progress, and field preparations. The company remains active across early-stage exploration assets and provided visibility into its operational planning.
Drug Development Progress: Solvonis Therapeutics Plans Ahead
Solvonis Therapeutics shared new steps being taken toward advancing its investigational therapy. The company confirmed preparations for upcoming trial stages, including document submission and coordination with research centres.
The focus remained on execution readiness for the trial environment, supporting future patient enrolment and site activation. Internal updates included reference to data management tools and operational timelines for drug development milestones.
